Biotech Values

[biomaven0]

unsophisticated drugs (which copaxone largely is in the scheme of things)

You have to be kidding, right? Copaxone has to be among the most sophisticated drugs I know of, both in terms of its composition and its mode of action.

Personally I think the chance that Teva is pushing Luponex under a different name and claiming that it meets the FDA's five standards is close to zero. I continue to believe that enox presents a bigger opportunity for Teva than virtually any other generic for the obvious reason that its sales would not fall off a cliff after a 6 month exclusivity period like all their other generics.

But at this point I think everyone is flogging a dead horse here. Trying to parse the Teva statements word for word and pause by pause only gets you so far.

A more productive discussion in my view is pushing the investment community to think about holding a small amount of MNTA as an insurance policy on their Teva holdings against a copaxone approval. It's not a crazy strategy by any means if you look at the numbers.

Peter